Management
Earle Martin
Mr. Martin is a founder and Managing Director of Sequent. He is an experienced CEO who previously founded PRA International, one of the largest clinical research organizations (CROs) in the world and is currently a partner in NDA Partners, an international strategic consultancy specialized in medical product development. Mr. Martin handles proposals and contracts, business development and general management for Sequent.
Dr. Vladimir Vinnitsky
Dr. Vinnitsky, M.D., Ph.D., D.Sc. is a founder and Managing Director of Sequent. He is an experienced clinician and scientists with more than 35 years of research experience. He received his Medical Doctor degree in 1966 from Bogomoletz National Medical University in Kiev, Ukraine, his Ph.D. in Oncology in 1971 from the Institute for Oncology Problems in Kiev, and Doctor of Medical Sciences degree in Oncology in 1982 from the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology (IEPOR) in Kiev. He is author of more than 150 scientific articles in peer reviewed scientific journals and three monographs. Dr. Vinnitsky was previously Chief of the Department and Deputy Director of IEPOR in Kiev – one of the largest cancer research centers in Europe. Although a permanent resident of the U.S., Dr. Vinnitsky retains his position as Professor of Oncology at IEPOR. His unique position as a member of the senior scientific staff at IEPOR and high level scientific and administrative contacts within some of the most prestigious research Institutions in Eastern Europe have enabled Sequent to establish a number of productive, long-term collaborations. Dr. Vinnitsky handles operations in the U.S. including interfacing with staff in Kiev for review of protocols, study progress and study reports.
Dr. Anatoly Soloviev
Anatoly Soloviev, M.D., Ph.D., D.Sc. is Director of Operations for Sequent in Kiev and was instrumental in bringing the research laboratories there into compliance with GLP. He received his Medical Doctor degree in 1972 from Orenburg State Medical Institute in Russia, Ph.D. in Physiology from A.A Bogomoletz Institite of Physiology in Kiev in 1978, and Doctor of Sciences degree in Physiology in 1988 from the A.A. Bogomoletsz Institute of Physiology in Kiev. Dr. Soloviev has a broad knowledge of experimental methods and techniques in pharmacology and toxicology. He is the Head of the Cellular Pharmacology group, State Pharmacological Center; Head of the Interagency Laboratory for Preclinical Drug Trials, Head of the Department for Experimental Therapeutics, Institute of Pharmacology & Toxicology, Academy of Medical Sciences,Kiev, Ukraine. He has more than 25 years of experience in toxicology, pharmacology and pathophysiology and is author of more than 200 scientific articles in peer reviewed scientific journals and 5 monographs.
Dr. Galyna Solyanyk
Galyna Solyanyk, Ph.D., D.Sc. is Director of Quality Assurance for Sequent Development in Kiev. She received her Master of Science in Mathematics, Physics and Biology in 1976 and Ph.D. in Biophysics in 1980 from the Moscow Institute of Physics and Technology, and Doctor of Sciences in Biophysics in 2000 from the V. N. Karazin Kharkiv National University in Kharkiv. Dr. Solyanyk is Head of the Department of Experimental Cancer Therapeutics at the R.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology (IEPOR). She has more than 20 years of experience in oncology research, pharmacokinetics, and pharmacodynamics and has published more than 100 scientific articles in peer reviewed scientific journals.
